Psychotropic Drug Indications
A comparative list of psychotropic medications with their mood disorder indications (bipolar disorder, major depressive disorder, treatment resistant depression, premenstrual dysphoric disorder, and others).
Schizophrenia
Mental Health Disorders Tied to Higher COVID-19 Mortality
Mental health disorders are associated with increased COVID-19-related mortality.
PsyMetRiC: a Metabolic Risk Calculator for Young Patients With Psychosis
Individuals with psychotic disorders have a 10 to 15 year shorter life span compared with the general population, mostly due to physical conditions like obesity, cardiovascular disease, and type 2 diabetes. A cardiometabolic risk prediction algorithm can offer informed treatment decisions in order to prevent long-term cardiometabolic outcomes.
Lybalvi Approved for Schizophrenia, Bipolar I Disorder
The approval was based on data from 27 clinical studies, including the phase 3 ENLIGHTEN-1 and ENLIGHTEN-2 studies.
Brexpiprazole Provides Short- and Long-Term Benefits in Schizophrenia
The goal of the researchers was to describe the short- and long-term effects of brexpiprazole on Positive and Negative Syndrome Scale (PANSS) “Marder factors.”
Undervaccination for COVID-19 Found for Individuals With Schizophrenia
Individuals with schizophrenia are undervaccinated against COVID-19 compared with age- and gender-matched controls in Israel.
Novel Glycine Transporter Inhibitor Gets Breakthrough Tx Status for Cognitive Impairment With Schizophrenia
The designation is based on results from a phase 2 trial that evaluated the efficacy and safety of 4 different doses of BI 425809 orally once daily in adults with CIAS for 12 weeks.
Dexmedetomidine Oral Film Under Review for Agitation With Schizophrenia, Bipolar Disorder
In both trials, BXCL501 demonstrated statistically significant, rapid and durable improvements vs placebo across multiple agitation scales.
Recommendations for Long-Acting Injectable Antipsychotics in Schizophrenia
Several clinical practice guidelines on the treatment of schizophrenia have recently been updated in the United States. In order to understand the recommendations of current clinical practice guidelines, the study authors conducted a systematic literature review.
Study Shows Patients with Schizophrenia Have Higher Rates of Cardiovascular Autonomic Neuropathy
Researchers compared standard cardiovascular autonomic reflex tests results among patients with schizophrenia and psychiatrically healthy controls at a university hospital in Denmark.
- Loading...
Loading...
Next post in Schizophrenia and Psychoses
Loading... 
Loading...